Impact Factor
3.27
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.90
413 total citations
h5-index
24
h5 depth signal
Cited share
68.5%
100 of 146
Total citations
413
Citation footprint
Metric signal
2.48
External metric anchor
Self-citation
0.7%
3 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
388
United Kingdom
141
Italy
125
Canada
79
Netherlands
53
Citing Fields of Research
Cardiology
833
Vascular Disorders
83
Diabetes
71
Lipids
66
Autonomic Function
49
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,911
Articles tracked across the journal lifetime
Indexed publication set
146
100 cited publications
Last 12 months
97
8.1 publications/month
Open access share
19.6%
19 OA publications in the last year
Leading citing country
United States
388 citing publications
Leading citing field
Cardiology
833 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1, May 2003-
v1n1, May 2003-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Broad Categories
Cardiology
Therapeutics
Vascular Diseases
MeSH Descriptors
Cardiovascular Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/14779072.2026.2749914
Open DOI
Post-treatment risks of transcatheter aortic valve implantation: should we be increasing preventative measures?
02
03
DOI 10.1080/14779072.2026.2745395
Open DOI
Micro- and nanoplastics as emerging cardiovascular risk factors: a new atherogenic player?
1. Global plastic production has continued to grow, exceeding 400 million tons in 2022, and it is estimated that more than 12 billion tons of plastic waste will be present in ecosystems by 2050 [1,...
04
DOI 10.1080/14779072.2026.2748716
Open DOI
Complications associated with thoracic endovascular aortic repair: highlighting the role of peri- and post-operative cardiac monitoring
Thoracic endovascular aortic repair (TEVAR) is first-line therapy for most descending thoracic aortic pathologies, yet it is performed in patients with a heavy burden of coronary disease, hypertension and limited cardiac reserve, and its...
05
DOI 10.1080/14779072.2026.2747542
Open DOI
The influence of loneliness & social isolation on cardiovascular risk factors: a narrative review
06
DOI 10.1080/14779072.2026.2745393
Open DOI
Recent advances in hypertension genomics and RNA interference-based therapeutics: the key to future management?
1. Hypertension remains a leading cause of cardiovascular morbidity and mortality globally, associated with the highest population-attributable fractions for cardiovascular disease among metabolic ...
07
DOI 10.1080/14779072.2026.2743947
Open DOI
Pregnancy-associated cardiac remodeling: from physiological adaptation to long-term cardiovascular risk
08
DOI 10.1080/14779072.2026.2744007
Open DOI
Advances in left bundle branch area pacing: current evidence, clinical applications, and future perspectives
09
DOI 10.1080/14779072.2026.2741509
Open DOI
Diagnosis of familial hypercholesterolemia through population screening
1. Familial hypercholesterolaemia (FH) is a predominantly autosomal dominant disorder affecting clearance of low-density lipoprotein cholesterol (LDL-C) mediated by the LDL (apolipoprotein B/E) rec...
10
DOI 10.1080/14779072.2026.2735936
Open DOI
Beating the heart failure epidemic: can emerging cell therapies deliver what conventional approaches cannot?
1. Heart failure is a major clinical and public health challenge, affecting an estimated 55.5 million people worldwide [1]. Approximately 6.7 million Americans are currently living with heart failu...
Bibliographical & Catalog Notes
Title from cover.
Description based on: Vol. 2, no. 1 (Jan. 2004).
Vol. 1 complete in 4 no.
Also issued online.